MindWalk Holdings (HYFT) Liabilities and Shareholders Equity (2020 - 2026)
MindWalk Holdings' (HYFT) quarterly Liabilities and Shareholders Equity came in at $15.6 million in Q2 2026, down 50.07% year-over-year from $31.2 million in Q2 2025, and down 5.86% quarter-over-quarter from $16.6 million in Q1 2026.
Analysis
MindWalk Holdings (HYFT) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has reported Liabilities and Shareholders Equity for 7 consecutive years, with $15.6 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Liabilities and Shareholders Equity fell 50.07% year-over-year to $15.6 million in Q2 2026; TTM through Apr 2026 was $80.6 million, a 46.43% decrease from a year earlier, with the FY2026 full-year figure at $15.5 million, down 51.44% from the prior year.
- Liabilities and Shareholders Equity was $15.6 million for Q2 2026 at MindWalk Holdings, down from $16.6 million in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $73.9 million in Q2 2022 and troughed at $15.6 million in Q2 2026.
- A 5-year average of $44.9 million and a median of $44.4 million in 2022 frame the typical range for Liabilities and Shareholders Equity.
- Across the five-year window, Liabilities and Shareholders Equity jumped 39.02% in 2022 and sank 57.15% in 2025, its largest moves.
- Over 5 years, Liabilities and Shareholders Equity stood at $62.3 million in 2022, then slipped by 10.5% to $55.8 million in 2023, then fell by 21.25% to $43.9 million in 2024, then slumped by 57.15% to $18.8 million in 2025, then slipped by 17.13% to $15.6 million in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $15.6 million (Q2 2026), $16.6 million (Q1 2026), and $18.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 29.88 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 2.06 Bn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 16.40 Bn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 7.53 Bn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 2.71 Bn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 1.83 Bn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 990.05 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 33.29 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 12.42 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 3.85 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 15.59 Mn |
| Jan 31, 2026 | 16.56 Mn |
| Oct 31, 2025 | 18.82 Mn |
| Jul 31, 2025 | 29.66 Mn |
| Apr 30, 2025 | 31.23 Mn |
| Jan 31, 2025 | 32.08 Mn |
| Oct 31, 2024 | 43.91 Mn |
| Jul 31, 2024 | 43.31 Mn |
| Apr 30, 2024 | 44.24 Mn |
| Jan 31, 2024 | 58.21 Mn |
| Oct 31, 2023 | 55.76 Mn |
| Jul 31, 2023 | 57.38 Mn |
| Apr 30, 2023 | 57.51 Mn |
| Jan 31, 2023 | 61.12 Mn |
| Oct 31, 2022 | 62.31 Mn |
| Jul 31, 2022 | 62.16 Mn |
| Apr 30, 2022 | 73.94 Mn |
| Jan 31, 2022 | 44.60 Mn |
| Oct 31, 2021 | 47.99 Mn |
| Jul 31, 2021 | 52.45 Mn |